1. Home
  2. LSBK vs OKUR Comparison

LSBK vs OKUR Comparison

Compare LSBK & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSBK
  • OKUR
  • Stock Information
  • Founded
  • LSBK 1891
  • OKUR 2011
  • Country
  • LSBK United States
  • OKUR United States
  • Employees
  • LSBK N/A
  • OKUR N/A
  • Industry
  • LSBK Savings Institutions
  • OKUR
  • Sector
  • LSBK Finance
  • OKUR
  • Exchange
  • LSBK Nasdaq
  • OKUR NYSE
  • Market Cap
  • LSBK N/A
  • OKUR 76.6M
  • IPO Year
  • LSBK 2006
  • OKUR N/A
  • Fundamental
  • Price
  • LSBK $15.48
  • OKUR $2.60
  • Analyst Decision
  • LSBK
  • OKUR Strong Buy
  • Analyst Count
  • LSBK 0
  • OKUR 4
  • Target Price
  • LSBK N/A
  • OKUR $32.25
  • AVG Volume (30 Days)
  • LSBK 6.4K
  • OKUR 74.0K
  • Earning Date
  • LSBK 05-06-2025
  • OKUR 05-14-2025
  • Dividend Yield
  • LSBK 4.71%
  • OKUR N/A
  • EPS Growth
  • LSBK 6.97
  • OKUR N/A
  • EPS
  • LSBK 0.88
  • OKUR N/A
  • Revenue
  • LSBK $25,846,000.00
  • OKUR N/A
  • Revenue This Year
  • LSBK N/A
  • OKUR N/A
  • Revenue Next Year
  • LSBK N/A
  • OKUR N/A
  • P/E Ratio
  • LSBK $17.42
  • OKUR N/A
  • Revenue Growth
  • LSBK N/A
  • OKUR N/A
  • 52 Week Low
  • LSBK $11.00
  • OKUR $2.50
  • 52 Week High
  • LSBK $16.95
  • OKUR $20.00
  • Technical
  • Relative Strength Index (RSI)
  • LSBK 58.47
  • OKUR N/A
  • Support Level
  • LSBK $14.20
  • OKUR N/A
  • Resistance Level
  • LSBK $14.69
  • OKUR N/A
  • Average True Range (ATR)
  • LSBK 0.31
  • OKUR 0.00
  • MACD
  • LSBK 0.14
  • OKUR 0.00
  • Stochastic Oscillator
  • LSBK 100.00
  • OKUR 0.00

About OKUR ONKURE THERAPEUTICS INC

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Share on Social Networks: